The addition of MJ Research and new product launches should propel Bio-Rad Laboratories — or at least its life sciences unit — to double-digit sales growth in the fourth quarter, Bio-Rad said last week.

“The joining of forces with MJ Research is a move that really expands our offering in the DNA-amplification market,” Norman Schwartz, CEO of Bio-Rad, told investors and analysts in a conference call to discuss its results for the quarter ending Sept. 30. “This is exciting for us; it’s a large growing market with lots of areas to participate in.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.